Your browser doesn't support javascript.
loading
Genomic and transcriptomic analysis of imatinib resistance in gastrointestinal stromal tumors.
Takahashi, Tsuyoshi; Elzawahry, Asmaa; Mimaki, Sachiyo; Furukawa, Eisaku; Nakatsuka, Rie; Nakamura, Hiromi; Nishigaki, Takahiko; Serada, Satoshi; Naka, Tetsuji; Hirota, Seiichi; Shibata, Tatsuhiro; Tsuchihara, Katsuya; Nishida, Toshirou; Kato, Mamoru.
Afiliação
  • Takahashi T; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 2-2 E2, Yamadaoka, Suita City, Osaka, 565-0871, Japan.
  • Elzawahry A; Department of Bioinformatics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Mimaki S; JST, CREST, 5-3 Yonbancho, Chiyoda-ku, Tokyo, 102-0081, Japan.
  • Furukawa E; Division of Translational Research, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
  • Nakatsuka R; Department of Bioinformatics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Nakamura H; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 2-2 E2, Yamadaoka, Suita City, Osaka, 565-0871, Japan.
  • Nishigaki T; Division of Cancer Genomics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Serada S; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 2-2 E2, Yamadaoka, Suita City, Osaka, 565-0871, Japan.
  • Naka T; Laboratory for Immune Signal, National Institute of Biomedical Innovation, 7-6-8 Saito-Asagi, Ibaraki City, Osaka, 567-0085, Japan.
  • Hirota S; Laboratory for Immune Signal, National Institute of Biomedical Innovation, 7-6-8 Saito-Asagi, Ibaraki City, Osaka, 567-0085, Japan.
  • Shibata T; Department of Surgical Pathology, Hyogo Medical College, 1-1, Mukogawa-cho, Nishinomiya City, Hyogo, 663-8501, Japan.
  • Tsuchihara K; Division of Cancer Genomics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Nishida T; Division of Translational Research, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
  • Kato M; Department of Surgery, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
Genes Chromosomes Cancer ; 56(4): 303-313, 2017 04.
Article em En | MEDLINE | ID: mdl-27997714
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Resistencia a Medicamentos Antineoplásicos / Perfilação da Expressão Gênica / Genômica / Tumores do Estroma Gastrointestinal / Mesilato de Imatinib Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Resistencia a Medicamentos Antineoplásicos / Perfilação da Expressão Gênica / Genômica / Tumores do Estroma Gastrointestinal / Mesilato de Imatinib Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article